{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T17:56:51Z","timestamp":1755799011861,"version":"3.44.0"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T00:00:00Z","timestamp":1749686400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["IJC Heart & Vasculature"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.ijcha.2025.101723","type":"journal-article","created":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T13:25:16Z","timestamp":1750339516000},"page":"101723","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Intravenous iron for iron deficiency in heart failure with preserved ejection fraction. A multivariate analysis"],"prefix":"10.1016","volume":"59","author":[{"given":"Viviane","family":"Noverraz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sebastian","family":"Carballo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Carballo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philippe","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolas","family":"Garin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcha.2025.101723_b0005","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC guidelines for the diagnostic and treatment of acute and chronic heart failure","author":"McDonagh","year":"2021","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcha.2025.101723_b0010","first-page":"3272","article-title":"Global burden of heart failure: a comprehensive and updated review of epidemiology","author":"Savarese","year":"2022","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.ijcha.2025.101723_b0015","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1002\/ejhf.1858","article-title":"Epidemiology of heart failure","author":"Groenewegen","year":"2020","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.ijcha.2025.101723_b0020","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1056\/NEJMoa2407107","article-title":"Finerenone in Heart failure with mildly reduced or preserved ejection Fraction","author":"Solomon","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcha.2025.101723_b0025","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1056\/NEJMra2115011","article-title":"Gliflozins in the Management of Cardiovascular Disease","author":"Braunwald","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcha.2025.101723_b0030","doi-asserted-by":"crossref","first-page":"3627","DOI":"10.1093\/eurheartj\/ehad195","article-title":"2023 focused update of the 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure","author":"McDonagh","year":"2023","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcha.2025.101723_b0035","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/joim.13004","article-title":"Iron deficiency anaemia revisited","author":"Cappellini","year":"2020","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.ijcha.2025.101723_b0040","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1002\/ejhf.236","article-title":"Iron therapy for the treatment of iron deficiency in chronic heart failure: intravenous or oral?","author":"McDonagh","year":"2015","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.ijcha.2025.101723_b0045","unstructured":"P. R. Kalra, J. G. F. Cleland, M. C. Petrie, et al., \u201cIntravenous ferric derisomaltose in patients with heart failure and iron deficiency in the UK (IRONMAN): an investigator-initiated, prospective, randomised, open-label, blinded-endpoint trial,\u201d The Lancet, pp. 2199-2209, 2022."},{"key":"10.1016\/j.ijcha.2025.101723_b0050","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1056\/NEJMoa0908355","article-title":"Ferric Carboxymaltose in patients with Heart failure and Iron deficiency","author":"Anker","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcha.2025.101723_b0055","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1093\/eurheartj\/ehu385","article-title":"Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency","author":"Ponikowski","year":"2015","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcha.2025.101723_b0060","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1016\/S0140-6736(20)32339-4","article-title":"Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trial","author":"Ponikowski","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.ijcha.2025.101723_b0065","doi-asserted-by":"crossref","unstructured":"S. v. Haehling, W. Doehner, R. Evertz, T. Garfias-Veitl, C. Derad, M. Diek and M. Karakas, \u201cFerric carboxymaltose and exercise capacity in heart failure with preserved ejection fraction and iron deficiency: the FAIR-HFpEF trial,\u201d European Heart Journal, pp. 3789-3800, 2024.","DOI":"10.1093\/eurheartj\/ehae479"},{"key":"10.1016\/j.ijcha.2025.101723_b0070","doi-asserted-by":"crossref","DOI":"10.3390\/jcm8101569","article-title":"Iron deficiency in acute decompensated Heart failure","author":"Beale","year":"2019","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.ijcha.2025.101723_b0075","doi-asserted-by":"crossref","DOI":"10.3390\/life12111828","article-title":"Why Iron deficiency in acute Heart failure should be treated: a real-world clinical Practice study","author":"Lopez-Vilella","year":"2022","journal-title":"Life"},{"key":"10.1016\/j.ijcha.2025.101723_b0080","doi-asserted-by":"crossref","DOI":"10.1177\/10742484211055639","article-title":"IV sodium ferric gluconate complex in patients hospitalized due to acute decompensated Heart failure and Iron deficiency","author":"Borreda","year":"2022","journal-title":"J. Cardiovasc. Pharmacol. Ther."},{"key":"10.1016\/j.ijcha.2025.101723_b0085","doi-asserted-by":"crossref","DOI":"10.3390\/nu14235057","article-title":"Effect of ferric Carboxymaltose supplementation in patients with Heart failure with preserved ejection Fraction: role of attenuated oxidative stress and improved endothelial function","author":"Mollace","year":"2022","journal-title":"Nutrients"},{"key":"10.1016\/j.ijcha.2025.101723_b0090","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.revmed.2012.04.006","article-title":"Actualit\u00e9 du m\u00e9tabolisme du fer","volume":"34","author":"Beaumont","year":"2013","journal-title":"La Revue De M\u00e9decine Interne"},{"key":"10.1016\/j.ijcha.2025.101723_b0095","doi-asserted-by":"crossref","DOI":"10.1007\/s11897-013-0155-7","article-title":"The Emerging epidemic of Heart failure with preserved ejection Fraction","volume":"10","author":"Oktay","year":"2013","journal-title":"Curr. Heart Fail. Rep."},{"key":"10.1016\/j.ijcha.2025.101723_b0100","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jacc.2013.02.092","article-title":"A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation","volume":"62","author":"Paulus","year":"2013","journal-title":"J. Am. Coll. Cardiol."}],"container-title":["IJC Heart & Vasculature"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352906725001265?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352906725001265?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T16:05:02Z","timestamp":1755619502000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352906725001265"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":20,"alternative-id":["S2352906725001265"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcha.2025.101723","relation":{},"ISSN":["2352-9067"],"issn-type":[{"type":"print","value":"2352-9067"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intravenous iron for iron deficiency in heart failure with preserved ejection fraction. A multivariate analysis","name":"articletitle","label":"Article Title"},{"value":"IJC Heart & Vasculature","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcha.2025.101723","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"101723"}}